BMY
Bristol-Myers Squibb CompanyNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$117.15B
P/E Ratio
16.07
EPS
$3.57
Beta
0.26
52W High
$62.25
52W Low
$41.46
50-Day MA
$59.53
200-Day MA
$52.00
Dividend Yield
4.29%
Profit Margin
15.00%
Forward P/E
9.27
PEG Ratio
23.18
About Bristol-Myers Squibb Company
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
Fundamentals
| Revenue (TTM) | $48.48B |
| Gross Profit (TTM) | $34.90B |
| EBITDA | $18.97B |
| Operating Margin | 33.00% |
| Return on Equity | 38.70% |
| Return on Assets | 10.70% |
| Revenue/Share (TTM) | $23.82 |
| Book Value | $9.83 |
| Price-to-Book | 6.37 |
| Price-to-Sales (TTM) | 2.42 |
| EV/Revenue | 3.204 |
| EV/EBITDA | 10.84 |
| Quarterly Earnings Growth (YoY) | 9.20% |
| Quarterly Revenue Growth (YoY) | 2.60% |
| Shares Outstanding | $2.04B |
| Float | $2.04B |
| % Insiders | 0.09% |
| % Institutions | 83.38% |
Historical Volatility
HV 10-Day
37.08%
HV 20-Day
32.20%
HV 30-Day
30.31%
HV 60-Day
26.49%
HV Rank
66.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($63.32 target)
4
Strong Buy6
Buy18
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026